Epigenetic regulation in neural crest development  by Hu, Na et al.
Review
Epigenetic regulation in neural crest development
Na Hu a,1, Pablo H. Strobl-Mazzulla b,n,1, Marianne E. Bronner a
a Division of Biology and Biological Engineering, 139-74, California Institute of Technology, Pasadena, CA 91125, USA
b Laboratory of Developmental Biology, Instituto de Investigaciones Biotecnológicas—Instituto Tecnológico de Chascomús (CONICET-UNSAM),
Chascomús, Argentina
a r t i c l e i n f o
Article history:
Received 20 March 2014
Received in revised form
17 September 2014
Accepted 25 September 2014
Available online 24 October 2014
Keywords:
Neural crest
Epigenetic
Development
a b s t r a c t
The neural crest is a migratory and multipotent cell population that plays a crucial role in many aspects
of embryonic development. In all vertebrate embryos, these cells emerge from the dorsal neural tube
then migrate long distances to different regions of the body, where they contribute to formation of many
cell types and structures. These include much of the peripheral nervous system, craniofacial skeleton,
smooth muscle, and pigmentation of the skin. The best-studied regulatory events guiding neural crest
development are mediated by transcription factors and signaling molecules. In recent years, however,
growing evidence supports an important role for epigenetic regulation as an additional mechanism for
controlling the timing and level of gene expression at different stages of neural crest development. Here,
we summarize the process of neural crest formation, with focus on the role of epigenetic regulation in
neural crest speciﬁcation, migration, and differentiation as well as in neural crest related birth defects
and diseases.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Neural crest cells are a population of multipotent stem/pro-
genitor cells that are induced during gastrulation at the neural
plate border, between the neural and non-neural ectoderm. By
neurulation, deﬁnitive neural crest cells are speciﬁed as premi-
gratory cells within the dorsal neural tube and initiate expression
of typical neural crest markers like FoxD3 and Sox10. They then
emerge from the neural tube by undergoing an epithelial to
mesenchymal transition (EMT) whereby they delaminate from
the neuroepithelium, assume a mesenchymal morphology and
migrate extensively to different parts of the body. After migration,
they differentiate into numerous derivatives including neurons
and glia of the peripheral nervous system, melanocytes, portions
of the cardiac outﬂow tract, craniofacial bone and cartilage, and
smooth muscle of major blood vessels (Bronner and LaBonne,
2012; Sauka-Spengler and Bronner-Fraser, 2008; Sauka-Spengler
and Bronner, 2010). Understanding neural crest development is
important because these cells are involved in a variety of birth
defects, diseases and cancers, including cleft lip and palate, heart
defects, Hirschprung’s disease, melanoma and neuroﬁbromatosis.
There is good evidence that transcriptional events are critical
for many aspects of neural crest development. A neural crest gene
regulatory network (GRN) (Meulemans and Bronner-Fraser, 2004)
comprised of transcriptional and signaling events has been pro-
posed to function in a feed-forward series of regulatory circuits
(Betancur et al., 2010; Sauka-Spengler and Bronner-Fraser, 2006).
This neural crest GRN appears to be highly conserved throughout
vertebrates, including basal agnathans (Sauka-Spengler et al.,
2007), suggesting that these regulatory mechanisms were in place
before the divergence of jawed and jawless vertebrates, likely to
the base of the origin of vertebrates at 550 million years ago.
In addition to transcriptional regulation, there is growing evi-
dence to support roles for epigenetic regulation as critical for many
aspects of neural crest development, most notably in controlling the
timing of gene expression at different developmental stages. Here
we discuss the critical role of epigenetic regulation during neural
crest development and disease and some examples of how it
impinges upon the neural crest GRN.
Overview of epigenetic regulation
Epigenetic modiﬁcations are deﬁned as mechanisms that reg-
ulate gene expression without altering the underlying sequence of
DNA (Bernstein et al., 2007). However, recent changes in the usage
of the term have led to the suggestion that the requirement of
heritability be dropped and that epigenetic events might better
be deﬁned as “the structural adaptation of chromosomal regions
so as to register, signal or perpetuate altered activity states”
(Bird, 2007).
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Epigenetic modiﬁers can alter chromatin structure and genome
function through different processes such as DNA modiﬁcations,
histone modiﬁcations and variants, or can work as a complex to
regulate higher-level chromatin conformation in an ATP-depend-
ent manner. Depending on the speciﬁc type of regulator, the out-
come can either lead to gene activation, in which the chromatin is
relaxed and DNA is accessible to transcription factors, or to gene
repression, where chromatin is tightly packed and inaccessible to
transcriptional regulators.
Epigenetic modiﬁers, including “writers” and “erasers” that estab-
lish the epigenetic code (Fig. 1), are key regulators of developmental
events and also aberrant marks associated with many types of
cancers, and disease states (Portela and Esteller, 2010). Here, we
focus on various epigenetic regulators that have been shown to play a
role in neural crest development and neural crest related diseases
(Table 1). The epigenetic machinery falls into the following groups:
DNAmethylation, histone methylation, histone acetylation, Polycomb
repressive complex, ATP-dependent chromatin remodeling complex,
and other regulators that work with the epigenetic machinery to
regulate neural crest development. Different types of DNA and hist-
one modiﬁcations and family members of chromatin remodeling
complexes have been reviewed recently in (Liu and Xiao, 2011).
Neural crest induction and speciﬁcation
The process of neural crest formation is initiated by signaling
events, mediated by ligands including BMPs, WNTs and FGFs that
are secreted from neighboring tissues such as the neural and non-
neural ectoderm as well as the underlying mesoderm. During
gastrulation, these signals establish the neural plate border region
and initiate neural crest induction (Basch and Bronner-Fraser, 2006;
Heeg-Truesdell and LaBonne, 2004; Steventon et al., 2005;
Stuhlmiller and Garcia-Castro, 2012). The neural plate border region
has the competence to form not only neural crest cells but also
other cell types such as placode cells and some central nervous
system (CNS) cells. Signaling inputs in this region up-regulate a
group of transcription factors called ‘neural plate border speciﬁer
genes’ including Msx1/2, Pax3/7, Dlx5, AP2A, Gbx2 and Zic1. The
collective and overlapping expression of these genes confers upon
the neural plate border region the unique ability to form neural
crest cells. However, among all the neural plate border speciﬁers,
the Pax3/7 genes, when combined to Zic1, are sufﬁcient to activate a
bona ﬁde neural crest speciﬁcation program (Basch et al., 2006;
Hong and Saint-Jeannet, 2007; Milet et al., 2013; Monsoro-Burq
et al., 2005; Sato et al., 2005).
During neurulation, neural plate border circuitry activates a set of
transcription factors called the ‘neural crest speciﬁer genes’ in the
dorsal neural tube. These include genes like AP2, n-Myc, Id, Snail2,
FoxD3, Ets-1, Sox8/9/10, with some differences in the timing of their
initial expression (Khudyakov and Bronner-Fraser, 2009). These
factors function to maintain multipotency, promote their epithelial-
to-mesenchymal transition (EMT), initiate delamination and migra-
tion, while also affecting cell proliferation and survival. A bona ﬁde
neural crest cell is ﬁrst recognizable by the expression of transcrip-
tion factors such as FoxD3, Sox9, Snail2, and Sox10, which are
expressed in the dorsal neural tube and/or newly delaminated neural
crest cells, depending upon the species. These genes regulate down-
stream effector genes to promote EMT and migration, at which point
the neural crest cells become an identiﬁable population of
multipotent-migratory stem-like cells (Barembaum and Bronner-
Fraser, 2005; Gammill and Bronner-Fraser, 2003; Sauka-Spengler
and Bronner-Fraser, 2008).
Neural crest EMT and migration
During the epithelial to mesenchymal transition process, neural
crest cells alter cell junctions, adhesive properties and morphology
to acquire cell motility, which enables them to migrate long
distances to their ﬁnal destinations. For example, they switch from
expression of cadherins characteristic of epithelial cells to cadherins
of more mesenchymal character and lose tight junctions while esta-
blishing gap junctions. Neural crest speciﬁer genes like Snail2 and
FoxD3 regulate downstream genes to facilitate this process. As a
result, N-Cad and Cad6B are down-regulated and Cad7 is
up-regulated, along with an N-cad to E-cad switch and modulation
of gap junction proteins and integrins (Kerosuo and Bronner-Fraser,
2012; Strobl-Mazzulla and Bronner, 2012; Rogers et al., 2013). At
this point, neural crest cells become a distinct group of mesench-
ymal cells that delaminate from the neuroepithelium and migrate
out of the dorsal neural tube.
During their migration, neural crest cells interact with each
other and with their environment via signaling receptors such as
Fig. 1. Schematic diagram of the different epigenetic marks identiﬁed on histone H3 and DNA and their respective “writer”, “eraser” and “reader” proteins. Histone
methylations on red and green are associated with transcriptional repression and activation, respectively. TETs, Ten-Eleven translocation enzymes; DNMTs, DNA
methyltransferases; HATs, histone acetyltransferases; HDACs, histone deacetylases; HMTs, histone methyltransferases; and HDMTs, histone demethylases. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Neuropilins, Robo and Eph receptors, which respond to ligands that
guide them to speciﬁc destinations or restrict them from certain
territories (Betancur et al., 2010; Sauka-Spengler and Bronner-
Fraser, 2008).
At the end of migration, the expression of most neural crest
speciﬁer genes is down-regulated. However, expression of some
factors like Sox10 and FoxD3 remain on in a subset of cells and
contribute to terminal differentiation (Kelsh, 2006). Depending on
the axial location and time of emigration, neural crest cells give
rise to a wide variety of derivatives such as peripheral neurons and
glia, craniofacial skeleton, cartilage derivatives, and melanocytes.
(Betancur et al., 2010; Le Douarin, 1982).
DNA methylation in the neural crest
Methylation of the ﬁfth position of cytosine (5-methylcytosine,
5mC) is a highly conserved epigenetic modiﬁcation of DNA found in
most plant and animal models (Law and Jacobsen, 2010) and has a
profound impact on genome stability and gene expression (Jaenisch
and Bird, 2003; Smith and Meissner, 2013). During development,
epigenetic repression, via DNA methylation, is one of the most
common ways to shut down alternative pathways during cell type
speciﬁcation and lineage commitment (Cedar and Bergman, 2008).
DNA methylation also has been implicated in genome imprinting
and inactivation of the silent X chromosome (Ooi et al., 2009).
Although the DNA methylation pattern in somatic cells is stably
maintained, genome-wide DNA methylation is erased at speciﬁc
developmental stages such as in preimplantation embryos (Mayer
et al., 2000; Oswald et al., 2000; Sasaki and Matsui, 2008). Global
DNA demethylation is important for reprogramming cells in early
embryos to enable reacquisition of pluripotency (Mayer et al., 2000).
However, a unifying mechanistic understanding of active DNA dem-
ethylation has only been realized recently. After fertilization, the
repressive parental 5mC marks are erased by iterative oxidation by
TET proteins to generate oxidized cytosine bases known as
5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-car-
boxycytosine (5caC) (Kriaucionis and Heintz, 2009; Tahiliani et al.,
2009). As development proceeds, new DNA methylation marks are
established to gradually restrict the cell’s potential (Borgel et al.,
2010; Mayer et al., 2000; Reik, 2007). In mammalian cells, 60–90%
of the cytosine residues are methylated in the context of CpG
dinucleotides (Gardiner-Garden and Frommer, 1987; Namihira
et al., 2004). However, recent work suggests that non-CpG methyla-
tion is relatively abundant in oocytes, pluripotent embryonic stem
cells and mature neurons (Lister et al., 2013; Lister et al., 2009;
Table 1
Summary of epigenetic regulation in neural crest development.
Stage of NC
development
Gene
name
Epigenetic mark On/
Off
Downstream
targets
Role in NC development Citations
Neural crest speciﬁcation
DNMT3A DNA methylation targeting CpG
island
OFF Sox2/3, SoxE,
Snail2,FoxD3
Neural to neural crest transition Hu et al. (2012)
JmjD2A Histone deacetylase targeting
H3K9me3
ON Sox10, Snail2 Neural crest speciﬁcation Strobl-Mazzulla et al. (2010)
CHD7 ATP-dependent chromatin
remodeler
ON Sox9, Twist Neural crest speciﬁcation Eroglu et al. (2006)
Brg1 Chromatin remodeler ON Snail2 Neural crest induction Eroglu et al. (2006)
TSA HDAC inhibitor ON Bmp4, Pax3,
Sox9, Sox10
Trunk crest speciﬁcation Murko et al. (2013)
Neural crest EMT and migration
PHD12 Histone deacetylase complex
member
OFF Cad6B Neural crest EMT Strobl-Mazzulla and Bronner
(2012)
HDAC8 OFF Facial skeleton
RFC Co-factor of hMLL1 lysine
methyltransferase targeting H3K4me
ON Zic1, Snail2,FoxD3 Dorsal to ventral migration Li et al. (2011)
Neural crest differentiation
PHF8 Histone demethylase targeting
H4K20me1 and H3K9me1
ON MSXB Cranial facial jaw development Phillips et al. (2006), Qi et al.
(2010)
HDAC1 Removes acetylation OFF FoxD3, MITFa,
hoxb3a, dlx2,
dlx3
Melanoblast development; craniofacial and
peripheral neuron development
Ignatius et al. (2008), Ignatius
et al. (2013)
HDAC3 Removes acetylation OFF Smooth muscle and cardia outﬂow tract Singh et al. (2011)
HDAC8 Removes acetylation OFF Otx2, Lhx1 Cranial differentiation into skull Haberland et al. (2009)
DNMT3B DNA methylation OFF Lef1 Craniofacial structures, brain and retina
development
Rai et al. (2010)
HDAC4 Removes acetylation OFF Palatal skeleton formation DeLaurier et al. (2012)
G9a Histone methylation OFF Lef1 Craniofacial structures, brain and retina
development
Rai et al. (2010)
VPA HDAC inhibitor ON Neural tube defects, cleft lip and palate, and
cardiovascular defects
Alsdorf and Wyszynski (2005),
Wyszynski et al. (2005)
Ring1b/
Rnf2
Polycomb repressive complex 1 OFF Craniofacial chondrocytes differentiation van der Velden et al. (2013)
Ezh2 Polycomb repressive complex 2 OFF Hox genes Craniofacial skeleton formation Schwarz et al. (2014)
Syndromes and diseases
WSTF ATP-dependent chromatin
remodeler
ON Snail, Snail2 Williams syndrome Barnett et al. (2012), Yoshimura
et al. (2009)
Aebp2 Polycomb repression associated with
H3K27me3
OFF Sox10, Pax3,
Snail2
Hirschsprung’s disease and Waardenburg
syndrome
Kim et al. (2011)
CHD7 ATP-dependent chromatin
remodeler
ON Sox9, Twist CHARGE sindrome Eroglu et al. (2006)
HDAC4 Removes acetylation OFF Brachydactyly mental retardation
syndrome, oral clefts
Williams et al. (2010), Park
et al. (2006)
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Shirane et al., 2013; Xie et al., 2012); to date, the function of
mammalian non-CpG methylation remains unclear.
This process is mediated by the family of DNAmethyltransferases:
DNMT1, DNMT3A and 3B. These enzymes catalyze the transfer of a
methyl group on cytosine using S-adenosyl-L-methionine as a donor
(Turek-Plewa and Jagodzinski, 2005), thereby inhibiting interaction
of some proteins with DNA, while facilitating the binding of others
(Jaenisch and Bird, 2003; Smith and Meissner, 2013).
According to their function, the DNMTs can be categorized into
two main groups with DNMT1 representing the maintenance meth-
yltransferase and DNMT3A and 3B acting as de novo methyltrans-
ferases. DNMT1 preferably attacks the newly synthesized strand of
DNA during chromatin replication, repairing and maintaining the
pattern of methylation according to the parent strand (Chen and Li,
2006). The de novo methyltransferases (DNMT3A and 3B) are the
major players in tissue speciﬁc regulation during development,
establishing the initial CpG methylation pattern. Their activities can
be modulated by a catalytically inactive family member, DNMT3L
(Jurkowska et al., 2011; Siddique et al., 2012; Wienholz et al., 2010).
The de novo DNMTs recognize CpGs and newly methylate DNA
by transferring a methyl group to cytosine residues (Cheng and
Blumenthal, 2008). Such methylation of CpG sites, generally located
at the promoter region of a gene, is thought to inhibit gene exp-
ression, as shown in cancer and stem cells (Altun et al., 2010;
Miranda and Jones, 2007; Momparler and Bovenzi, 2000; Suzuki
and Bird, 2008). DNMT3A and its paralog DNMT3B have been shown
to be vital for normal mammalian development and play important
roles in disease (Ehrlich et al., 2008; Jaenisch and Bird, 2003; Linhart
et al., 2007; Yan et al., 2011). For example, Dnmt3A homozygous
knockout mice die several weeks after birth, and Dntm3B homo-
zygous knockout embryos have rostral neural tube defects and
growth impairment (Okano et al., 1999), suggesting a very important
role of these proteins during development.
In the chick embryo, Dnmt3A is predominantly expressed in the
neural crest territory and its loss of function results in down
regulation/loss of neural crest speciﬁer genes Sox10, Snail2, FoxD3,
and the expansion of neural genes Sox2 and Sox3 into the neural
crest territory (Hu et al., 2012). Intriguingly, Dnmt3A plays an early
function in repressing the neural genes Sox2 and Sox3 in the pres-
umptive neural crest region, and this down-regulation of neural
genes in the dorsal neural fold is a prerequisite to activate neural
crest speciﬁer genes (Hu et al., 2012).
Mutations in human Dnmt3B are found in ICF (immunodeﬁ-
ciency-centromeric instability-facial anomalies) syndrome, com-
prised of facial abnormalities such as widened nasal bridge and
hypotelorism, neurological dysfunction and other related defects
(Ehrlich et al., 2008; Jin et al., 2008). These defects are consistent
with an important role for DNMT3B in neural crest development. In
zebraﬁsh, DNMT3B and histone methyltransferase G9a cooperate to
regulate neurogenesis through Lef1 and play a critical role in
forming the precursors of craniofacial structures, brain and retina
(Rai et al., 2010). In human embryonic stem cells, knockdown of
Dnmt3B accelerates neural and neural crest differentiation and inc-
reases the expression of neural crest speciﬁer genes (Pax3, Pax7,
FoxD3, Sox10 and Snail2) (Martins-Taylor et al., 2012).
Dnmt3B expression is signiﬁcantly up-regulated during neural
crest induction in chicken embryos (Adams et al., 2008). In
contrast to the human syndrome and stem cell studies, however,
conditional knock-down of Dnmt3B in the mouse neural crest
using Wnt1- or Sox10-cre does not produce an apparent cranio-
facial phenotype (Jacques-Fricke et al., 2012). Wnt-1-Cre driven
knock-out of DNMT3B exhibits only mild migration defects of
dispersed Sox10 positive cells, that recover during cranial gang-
liogenesis (Jacques-Fricke et al., 2012). One possibility for the
difference between these ﬁndings in different species is that the
neural crest defect obtained in Dnmt3Bmutant mice may be due to
a requirement for this protein earlier during neural crest devel-
opment. Alternatively, this could reﬂect differences between
species, or may indicate that the primary function of DNMT3B is
in non-neural crest tissue.
Histone modiﬁcations
Histone proteins associate with compacting DNA strands and
organize them into structural components called nucleosomes. Each
nucleosome contains eight histones: two of each of the core
histones H2A, H2B, H3 and H4 form octameric structures called
nucleosome cores around which DNA is wrapped with unstructured
tails (Gibney and Nolan, 2010). The core histone proteins are highly
conserved throughout evolution and their tails are subject to post-
translational modiﬁcations such as methylation, acetylation, deace-
tylation, phosphorylation, ubiquitination, and sumoylation (Berger,
2007; Kouzarides, 2007), with modiﬁcation on histone H3 being one
of the best described to date (Fig. 1). New histone marks and new
types of histone modiﬁcations continue to be discovered (Tan et al.,
2011). Among these modiﬁcations, histone methylation and acet-
ylation are currently the best studied in neural crest cells and play
an essential role in neural crest development.
Histone methylation is associated with both active and repressive
transcription (Kouzarides, 2007). Histone methyltransferases add
methylation marks whereas histone demethylases remove them.
H3K4me3 (Histone 3 Lysine 4 trimethylation) established by
Trithorax group proteins is indicative of transcriptionally permissive
chromatin states, and is mostly found in the promoter regions of
genes (Akkers et al., 2009; Barski et al., 2007; Cheung et al., 2010; Pan
et al., 2007). H3K36me3 is associated with euchromatic regions that
are associated with active transcription and primarily found in gene
bodies. In contrast, H3K27me3 catalyzed by Polycomb repressive
complex (Schwartz et al., 2006; Simon and Kingston, 2009; Swigut
and Wysocka, 2007; Tolhuis et al., 2006), and H3K9me3 catalyzed by
G9a methyltransferase (Allan et al., 2012; Nielsen et al., 2001; Shi
et al., 2003) are associated with transcriptional repression.
During neurulation, the H3K9me3 mark is abundant in dorsal
compared with ventral neural tube cells, reﬂecting clear differ-
ences in the epigenetic background of neural crest versus neural
progenitor cells (Fig. 2). Histone demethylases such as members of
the Jumonji family can revert H3K9me3 and H3K36me3 (Tan et al.,
2008). Accordingly, JmjD2A (also known as Kdm4A) is the ﬁrst
epigenetic gene discovered to regulate neural crest speciﬁcation
via modulating H3K9me3 of neural crest genes (Strobl-Mazzulla
et al., 2010). JmjD2A is expressed in the neural crest forming
territory during speciﬁcation. Moreover, knocking down JmjD2A
causes dramatic loss of neural crest speciﬁer genes such as Sox10,
Snail2, and FoxD3. In vivo ChIP assays reveal direct interaction of
JmjD2A with Sox10 and Snail2 promoter regions that are occupied
by H3K9me3 (Strobl-Mazzulla et al., 2010). Thus, JmjD2A is
required to demethylate histones occupying the promoters at the
proper time and place to allow neural crest speciﬁcation to occur.
Consistent with the importance of histone demethylases in devel-
opment, patients with mutations in the histone demethylase PHF8, a
JmjC domain containing protein, have craniofacial deformities. PHF8
is capable of demethylating the repressive marks H4K20me1 and
H3K9me1 around the transcription start site to activate transcription.
In zebraﬁsh, PHF8 directly regulates homeodomain transcription
factor MsxB during cranial facial development especially in the lower
jaw (Phillips et al., 2006; Qi et al., 2010). This transcriptional regulator
has been previously implicated in regulation of neural crest develop-
ment in many vertebrate models (Maxson and Ishii, 2008; Monsoro-
Burq et al., 2005; Phillips et al., 2006; Takahashi et al., 2001).
Histone acetylation is associated with active transcription and
histone de-acetylation silences transcription (Jenuwein and Allis,
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2001). HATs and HDACs are two classes of enzymes that antag-
onize each other (Shahbazian and Grunstein, 2007). HATs (histone
acetyltransferases) transfer acetyl groups to lysines, and their binding
is correlated with active transcription (Carrozza et al., 2003;
Shahbazian and Grunstein, 2007). Acetylation neutralizes the charge
of lysine residues and weakens their interactions with negatively
charged DNA, allowing the chromatin structure to open up, thus
increasing accessibility to transcription factors (Ekwall, 2005; Wang
et al., 2009). HATs have also been identiﬁed as co-transcriptional
activators (Roth et al., 2001; Yang, 2004). In contrast, HDACs (histone
deacetylases) de-acetylate lysine residues and one of their major
functions is to remove acetyl groups added by HATs (Wang et al.,
2002). As a result, chromatin is reset to its tightly packed state (Hsieh
et al., 2004). As a consequence, HDACs have been identiﬁed as
transcriptional co-repressors (Kadosh and Struhl, 1997; Rundlett
et al., 1998).
Epigenetic annotation such as histone acetylation is closely
associated with enhancer activity and is a new, powerful tool to
identify neural crest cis-regulatory regions together with conserved
regulatory regions. For example, H3K27ac is associated with active
enhancers (Bonn et al., 2012; Cotney et al., 2012; Creyghton et al.,
2010; Heintzman et al., 2009; Rada-Iglesias et al., 2011). In human
neural crest cells derived from hESC, a tour de force ChIP-seq study
using antibodies to several histone marks reveals that active
enhancer regions are enriched with H3K27ac and H3K4me1 while
lacking H3K4me3 (Rada-Iglesias et al., 2012). Neural crest enhancer
elements that are conserved between human and chicken are both
enriched for H3K27ac. Moreover, the ﬁnding that a TFAP2A, tog-
ether with nuclear receptors NR2F1 and NR2F2, leads to the esta-
blishment of a transcriptionally permissive enhancer chromatin
states, opens the possibility to identify new important genes
involved in neural crest development (Rada-Iglesias et al., 2011).
Many have now been identiﬁed as a result of these studies and it
will be interesting to monitor their functional characterization.
In neural crest development, the HDAC inhibitor Trichostatin A
(TSA) promotes trunk neural crest cell speciﬁcation (Murko et al.,
2013). In chick, in ovo treatment with the inhibitor TSA induces
neural crest markers Bmp4, Pax3, Sox9 and Sox10, and dysregulates
the proper timing of expression of cadherins, such as Cad6B and
N-cad, resulting in premature loss of epithelial characteristics.
The HDAC repression complex also plays an essential role in
regulating neural crest migration. Premigratory neural crest cells
from the dorsal neural tube undergo an epithelial to mesenchymal
transition to gain migratory properties and travel to distant parts of
the body. The transcriptional repressor Snail2 has been reported to
directly repress transcription of the adhesion molecule Cad6B in
premigratory neural crest cells (Hatta et al., 1987; Nakagawa and
Takeichi, 1995; Taneyhill et al., 2007). Epigenetic regulation has been
shown to play a critical underlying molecular role in this repression
(Strobl-Mazzulla and Bronner, 2012). Interaction between an adaptor
protein, PHD12, and Snail2 recruits the repressive complex Sin3A/
HDAC to the Cad6B promoter region. As a result, Cad6B transcription
is repressed via histone deacetylation. Thus, the dual coordination
between epigenetic regulators, such as PHD12, and transcription
factors, such as Snail2, is required to cooperatively regulate the
process of neural crest EMT (Strobl-Mazzulla and Bronner, 2012).
Later in development, HDACs play important roles in regulating
downstream neural crest differentiation. HDAC1 has distinct spatial
Fig. 2. Transverse section through a chick embryo stained with an antibody to the H3K9me3 mark (red) illustrates variation in the abundance of the mark between
premigratory neural crest, at the dorsal aspect of the neural tube, and the ventral neural tube progenitors. After neural crest migration, evidenced by the HNK-1 marker (in
blue), none of those highly abundant H3K9me3 positive cells are observed on the entire neural tube (unpublished data). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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and temporal functions in neural crest-derived cells in zebraﬁsh as
it is involved in both melanophore speciﬁcation and craniofacial
cartilage development. HDAC1 mutant zebraﬁsh embryos exhibit a
severe reduction in the number of melanoblasts expressing MITFa, a
critical transcription factor for melanoblast development, and retain
prolonged FoxD3 expression in neural crest cells. FoxD3 physically
interacts with the MITFa promoter and reducing FoxD3 expression in
HDAC1 mutants partially rescues the melanoblast defects. Thus,
during normal melanogenesis, HDAC1 is required to repress FoxD3
expression that in turn de-represses MITFa to allow melanophore
speciﬁcation, migration and differentiation (Ignatius et al., 2008). In
addition, HDAC1 is also involved in neural crest derived craniofacial
and peripheral neuron development (Ignatius et al., 2013). Craniofa-
cial cartilage defects are observed in mutant HDAC1 zebraﬁsh in
which fewer branchial arch precursors marked by hoxb3a, dlx2, and
dlx3 are speciﬁed and chondrocyte precursors fail to differentiate.
The differentiation of enteric and dorsal root ganglion neurons in the
posterior gut and tail are also disrupted in these mutant embryos.
Interestingly, sympathetic neurons precursors can successfully
undergo generic neuronal differentiation but fail to become nora-
drenergic (Ignatius et al., 2013). Overall, HDAC1 is required for
distinct developmental processes and its activity is present in a
broad range of cell types during neural crest derived differentiation.
In zebraﬁsh craniofacial morphogenesis, embryos treated with
HDAC4 morpholino exhibit loss of cranial neural crest derived
palatal skeletal precursor cells and this later results in defects in
the developing palate including cleft plate and a shortened face
(DeLaurier et al., 2012). In human development, HDAC4 is also
highly associated with neural crest related diseases and syn-
dromes. Haploinsufﬁciency of HDAC4 is associated with brachy-
dactyly mental retardation syndrome with features such as cran-
iofacial and skeletal abnormalities (Williams et al., 2010). In
addition, high throughput SNP analysis has linked HDAC4 with
nonsyndromic oral clefts, a common birth defect closely related to
neural crest development (Park et al., 2006). Moreover, infants
exposed to valproic acid (VPA, an HDAC inhibitor), an anticonv-
ulsant and mood-stabilizing drug, during pregnancy have an
increased risk of neural crest and neural tube related malforma-
tions including cleft lip and palate, and cardiovascular defects
(Alsdorf and Wyszynski, 2005; Wyszynski et al., 2005).
Other HDACs important for neural crest development include
HDAC3 and 8. HDAC3 is crucial for the regulation of smooth muscle
differentiation and cardiac outﬂow tract formation during cardiac
neural crest development in mouse (Singh et al., 2011). Similarly,
conditional deletion of HDAC8, driven by Wnt1-Cre in mice, results in
loss of speciﬁc cranial skeletal elements. HDAC8 epigenetically controls
skull morphogenesis in neural crest-derived cells by repressing
homeobox transcription factors Otx2 and Lhx1 (Haberland et al., 2009).
Although histone deacetylation was originally thought to func-
tion by silencing genes via local compaction of the chromatin
structure, it is now clear that HDACs also can activate or maintain
the active state (Wang et al., 2009) by acting in concert with HATs.
Therefore, the level of histone acetylation and the presence of
HDACs at a speciﬁc gene locus do not necessarily correlate with
the activity status of the gene. For example, a recent study in mice
has demonstrated that both HDAC1 and HDAC2 direct the speci-
ﬁcation of neural crest cells into peripheral glia (Jacob et al., 2014)
by binding to the promoter region of the transcription factor Pax3
and activating its expression. In turn, Pax3 is required to maintain
Sox10 expression levels necessary to trigger expression of the fatty
acid binding protein 7 (Fabp7), one of the early determinants nec-
essary for the neural crest differentiation into Schwann cell pre-
cursors and satellite glia. Moreover, HDAC1/2 also bind to and
activate the promoter region of myelin protein P0, necessary for
the peripheral glial differentiation. Consistent with these observa-
tions, deletion of HDAC1/2 in mouse neural crest cells leads to
depletion of satellite glia and Schwann cell precursors in dorsal
root ganglia and peripheral nerves.
In summary, HDACs execute important functions in the control
of both enhancer activity and promoter regions of transcription
factors to regulate gene expression. Their activity affects numerous
aspects of neural crest development ranging from speciﬁcation to
migration and differentiation.
Polycomb repressive complex
The polycomb repressive complexes (PRC) epigenetically silence
the transcription of their target genes by catalyzing the trimethy-
lation of histone 3 lysine 27 (H3K27me3) (Mikkelsen et al., 2007;
Schuettengruber et al., 2007). Polycomb proteins are involved in
many events during embryonic development in a stage and time
dependent manner. PRC1 and PRC2 are both involved in the differ-
entiation of neural crest-derived craniofacial structures. During chon-
drogenesis and skeleton formation, Hox genes are normally turned off
in the cranial neural crest. EZH2, enhancer of zeste homolog 2, is one
of the four core subunits of PRC2. Conditional knockout of Ezh2 in pre-
migratory neural crest cells in mice leads to de-repression of Hox
genes in cranial neural crest cells, which in turn suppresses osteo-
chondrogeneis and prevents craniofacial cartilage and bone formation
(Schwarz et al., 2014). Similarly, Ring1b/Rnf2 (the single E3 ubiquitin
ligase) in the PRC1 complex regulates cranial neural crest differentia-
tion into chondrocytes (van der Velden et al., 2013). Zebraﬁsh Ring1b
mutants lack cranial cartilage, bone and musculature due to the
inability of cartilage precursors to differentiate into chondrocytes.
Interestingly, H3K27me3 and PRC proteins are reduced at the pro-
moter regions of neural crest speciﬁer genes upon knock-down of
DNMT3B in hESCs (Martins-Taylor et al., 2012) suggesting cross-
regulation between these epigenetic regulators.
In addition to cartilage differentiation, defects in PRC genes are
associated with neural crest related diseases and syndromes. Aebp2,
a component of the PRC2, is expressed in the neural crest territory
(Kim et al., 2009). Heterozygous mouse mutants of Aebp2 gene
present phenotypes similar to human patients with Hirschsprung’s
disease and Waardenburg syndrome. Both disorders are caused by
migratory and developmental defects in neural crest cells (Ahola
et al., 2009; Inoue et al., 2002; Kim et al., 2011). Expression levels of
key neural crest genes are affected in Aebp2 heterozyous mutants.
In particular, Sox10 is consistently down-regulated, similar to the
reduced SOX10 dosage frequently observed on Waardenburg syn-
drome type 4 human desease. It is possible, that Aebp2 misregula-
tion is responsible for Hirschsprung’s disease and Waardenburg
syndrome via improper epigenetic regulation of the neural crest
genes (Kim et al., 2011).
ATP-dependent chromatin remodelers
The ATP-dependent chromatin remodeling complexes such as
SWI/SNF, ISWI, and CHD regulate gene expression by changing the
position or structure of higher order chromatin in an ATP-dependent
manner. They create nucleosome-free regions to facilitate access of
DNA to transcription factors and regulatory proteins (Kwon and
Wagner, 2007; Wu et al., 2009). CHD7, an ATP-dependent chromatin
domain helicase DNA-binding domain member, cooperates with
PBAF (SWI/SNF chromatin remodeling complex (Muchardt and
Yaniv, 2001)) to promote neural crest speciﬁcation in hESC induced
to become neural crest cells. CHD7 activates core neural crest
transcriptional circuitry genes including Sox9 and Twist through
directly regulating their enhancer regions (Bajpai et al., 2010). Sixty-
seven percent of patients with CHARGE syndrome (a rare genetic
disorder) have CHD7 mutations (Zentner et al., 2010). CHD7
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impairment in Xenopus embryos recapitulates major CHARGE
syndrome features such as craniofacial malformations, peripheral
nervous system abnormalities and heart defects (Bajpai et al., 2010).
Consistent with this, CHD7 deﬁcient mice exhibit craniofacial
abnormalities (Bosman et al., 2005; Hurd et al., 2007; Layman et
al., 2009). Taken together, these data suggest that CHARGE syn-
drome is a result of CHD7 malfunction in early neural crest
development. In addition, in zebraﬁsh, Brg1, a member of the SWI/
SNF chromatin-remodeling complex, plays an important role in
neural crest induction, possibly via regulating the promoter region
of Snail2 (Eroglu et al., 2006).
WSFT, Williams syndrome transcription factor, is a major subunit
of two distinct ATP-dependent chromatin remodeling complexes:
WINAC and WICH (Barnett and Krebs, 2011). It is one of the genes
associated with Williams syndrome, a developmental disorder in
which patients have defects in neural crest derived tissues. These
include facial abnormalities, heart defects, and neural problems,
among other abnormalities. In Xenopus embryos, WSFT is expressed
in the migratory neural crest and branchial arches. Knock-down of
WSFT perturbs Snail and Snail2 expression in the branchial arches.
There are severe defects in neural crest migration and maintenance,
while neural crest induction is unaffected (Barnett et al., 2012). In
mice, WSFT heterozygotes exhibit cardiovascular abnormalities that
phenocopy Williams syndrome patients (Yoshimura et al., 2009).
Taken together, these data suggest that malfunction of WSFT during
neural crest development is a major contributor to Williams
syndrome.
Other epigenetic regulators
The reduced folate carrier (RFC) is a membrane-bound receptor
involved in folate uptake by cells. Mice lacking RFC1 develop multiple
defects including neural tube, craniofacial and heart abnormalities
(Gelineau-van Waes et al., 2008). In Xenopus, XRFC is expressed
exclusively in the neural crest domain and its morpholino-mediated
knockdown down-regulates neural crest markers such as Zic1, Snail2,
and FoxD3 (Li et al., 2011). As a result, Twist1 positive neural crest
cells fail to migrate ventrally and embryos exhibit similar phenotypes
to those observed in mice. In animal cap assays, knock-down of RFC
reduces the levels of H3K4me1 and H3K4me3. Over expressing lysine
transferase hMLL1 in XRFC MO treated embryos fully rescues Zic1
and FoxD3 expression and partially rescues Snail2 and Twist1
expression (Li et al., 2011). Taken together, these data suggest that
an RFC mediated folate metabolic pathway controls neural crest
development through epigenetic mechanisms.
Leo1 is a component of the Polymerase-Associated Factor (PAF1)
complex associated with chromatin remodeling and gene regulation
(He et al., 2004; Krogan et al., 2003; Simic et al., 2003). In zebraﬁsh
mutants with truncated Leo1 protein, there is reduced expression of
Crestin, Gch2, and Miftfa in neural crest derived cells (Nguyen et al.,
2010). As a consequence, mutants have phenotypes such as reduced
numbers of melanocyte, craniofacial cartilage, and glial cells. It is
interesting to speculate that Leo 1 may be essential for neural crest
differentiation, possibly through epigenetic regulations.
Conclusions
Many of the most common human birth defects are related to
abnormal neural crest development. Neural crest malformation
can lead to craniofacial defects like cleft lip and palate, heart
septation defects, and agangliogenesis of the colon (Jiang et al.,
2006; Tennyson et al., 1986; Youn et al., 2003). In addition, neural
crest cells are involved in a variety of diseases and syndromes such
as Hirschsprung’s disease (HSCR), Wardensburg syndrome (WS),
CHARGE syndrome and Williams Syndrome (Ahola et al., 2009;
Bajpai et al., 2010; Inoue et al., 2002; Kim et al., 2011; Yoshimura
et al., 2009). Although some of these syndromes are based in
transcriptional or metabolic events, others like CHARGE syndrome
clearly involve epigenetic factors.
Thus, in addition to transcriptional regulators, epigenetic modi-
ﬁers serve as important inputs that are crucial for proper neural crest
development. At a given time point, epigenetic modiﬁers control
aspects of neural crest development in a spatially and temporally
speciﬁc manner. They are capable of communicating at both the
promoter and enhancer regions to render DNA as accessible state for
transcription, poise an enhancer region for future activation, or
remove active marks to turn off transcription. Often, these regulators
cross-talk and work together to achieve their goals. For example,
DNA methyltransferases often work with histone methyltransferases
to shut down genes and histone demethylases read and remove
repressive marks along with histone acetylases to activate transcrip-
tion at the appropriate time. Each cell lineage is marked with
different combinations of epigenetic modiﬁcations at a given devel-
opmental time point. Uncovering these marks in neural crest cells
will be critical for understanding both neural crest development and
related diseases.
Epigenetic machinery also works closely with transcription
factors and lineage speciﬁc genes to achieve tissue speciﬁc regula-
tion. Most of the interactions between epigenetic regulators and
downstream transcriptional effectors reviewed here are correlative.
Only a few relationships have been proven to be direct. Future work
must dissect the molecular mechanisms underlying each predicted
interaction and identify new genes and regulatory circuits acting
during neural crest development. The tools to accomplish this goal
– high throughput technologies such as Chip-seq and RNA-seq
combined with in vivo perturbation analysis and genome editing –
are now in place. It will be of great value to expand our under-
standing of events underlying neural crest formation and gene
regulatory interactions at the mechanistic level, from both a
transcriptional and epigenetic vantage point.
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